Please login to the form below

Not currently logged in
Email:
Password:

Coagadex

This page shows the latest Coagadex news and features for those working in and with pharma, biotech and healthcare.

CHMP backs orphan drugs Uptravi and Coagadex

CHMP backs orphan drugs Uptravi and Coagadex

A CHMP recommendation is routinely followed within three months by a full European approval from the European Commission, so should see Uptravi, Coagadex and Empliciti licensed in the region by May.

Latest news

  • BPL bags FDA approval for rare bleeding disorder therapy BPL bags FDA approval for rare bleeding disorder therapy

    First drug approved for hereditary Factor X deficiency. UK firm Bio Products Laboratory (BPL) has won US approval for Coagadex, the first drug approved specifically for patients with the rare bleeding ... The company is also in the process of carrying

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics